Cancer Research Cell Death Mechanisms and Cancer Therapy  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 4361-4367, August 1, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takahashi, H. K.
Right arrow Articles by Hakomori, S.-i.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takahashi, H. K.
Right arrow Articles by Hakomori, S.-i.

Immunoglobulin G3 Monoclonal Antibody Directed to Tn Antigen (Tumor-associated {alpha}-N-Acetylgalactosaminyl Epitope) That Does Not Cross-React with Blood Group A Antigen1

Hélio K. Takahashi2, Rikiya Metoki3 and Sen-itiroh Hakomori

Department of Biochemical Oncology, Fred Hutchinson Cancer Research Center [H. K. T., S. H.], The Biomembrane Institute [R. M., S. H.], and Departments of Pathobiology, Microbiology, and Immunology, University of Washington [H. K. T., R. M., S. H.], Seattle, Washington 98104

An IgG3 monoclonal antibody (CU-1) directed to the Tn glycoprotein antigen, which does not cross-react with blood group A antigen, has been established after immunization of mice with a purified Tn antigen, followed by selection of hybridomas secreting antibodies with the desired specificity. The antibody binding with Tn antigen was inhibited by monosaccharide N-acetylgalactosamine (a mixture of {alpha} and ß anomers) and specifically by p-nitrophenyl-{alpha}-D-N-acetylgalactosaminide but not by p-nitrophenyl-ß-D-N-acetylgalactosaminide, and the antibody binding was competitively inhibited by an IgM anti-Tn antibody NCC-LU-81. The antibody was not reactive with blood group A antigen, in contrast to previously reported anti-Tn antibodies which showed various degrees of cross-reactivity. Immunoperoxidase staining of various tumors and normal tissues with CU-1 showed a strong preferential or specific staining of sections from various cancer tissues over normal counterpart tissues, except for goblet cells in colon and some mammary gland epithelia. The positive staining in cancer and normal tissues was independent of the blood group ABH status of the host. Among various human cell lines tested, a number of cancer cell lines showed various degrees of antibody binding activity, although the binding did not correlate with the pathohistological type of the tumor cell lines. The intensity of antibody binding to cells was not proportional to the susceptibility of cells to the antibody-dependent cytotoxicity.

1 This investigation has been supported by an Outstanding Investigator Grant from the National Cancer Institute, CA42505 (to S. H.) and a fellowship from CNPq, Brazil (H. T.).

2 Recipient of International Fogarty Fellowship FO5 TW03783. On leave of absence from Departamento de Bioquimica, C.P. 20.372, Escola Paulista de Medicina, S.P., Brazil.

3 On leave of absence from Department of Urology, Tohoku University School of Medicine.

Received 10/ 5/87. Revised 4/11/88. Accepted 4/26/88.




This article has been cited by other articles:


Home page
GlycobiologyHome page
C. Danussi, A. Coslovi, C. Campa, M. T Mucignat, P. Spessotto, F. Uggeri, S. Paoletti, and A. Colombatti
A newly generated functional antibody identifies Tn antigen as a novel determinant in the cancer cell-lymphatic endothelium interaction
Glycobiology, October 1, 2009; 19(10): 1056 - 1067.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
Q. Li, M. R. Anver, D. O. Butcher, and J. C. Gildersleeve
Resolving conflicting data on expression of the Tn antigen and implications for clinical trials with cancer vaccines
Mol. Cancer Ther., April 1, 2009; 8(4): 971 - 979.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
N. Miyahara, J. Shoda, T. Kawamoto, M. Furukawa, T. Ueda, T. Todoroki, N. Tanaka, K. Matsuo, Y. Yamada, K. Kohno, et al.
Expression of UDP-N-Acetyl-{alpha}-D-Galactosamine-Polypeptide N-Acetylgalactosaminyltransferase Isozyme 3 in the Subserosal Layer Correlates with Postsurgical Survival of Pathological Tumor Stage 2 Carcinoma of the Gallbladder
Clin. Cancer Res., March 15, 2004; 10(6): 2090 - 2099.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
M. S. Toledo, E. Suzuki, S. B. Levery, A. H. Straus, and H. K. Takahashi
Characterization of monoclonal antibody MEST-2 specific to glucosylceramide of fungi and plants
Glycobiology, January 1, 2001; 11(2): 105 - 112.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
G Huet, I Kim, C de Bolos, J. Lo-Guidice, O Moreau, B Hemon, C Richet, P Delannoy, F. Real, and P Degand
Characterization of mucins and proteoglycans synthesized by a mucin-secreting HT-29 cell subpopulation
J. Cell Sci., January 3, 1995; 108(3): 1275 - 1285.
[Abstract] [PDF]


Home page
J. Cell Sci.Home page
T Lesuffleur, N Porchet, J. Aubert, D Swallow, J. Gum, Y. Kim, F. Real, and A Zweibaum
Differential expression of the human mucin genes MUC1 to MUC5 in relation to growth and differentiation of different mucus-secreting HT-29 cell subpopulations
J. Cell Sci., January 11, 1993; 106(3): 771 - 783.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.